Ouyang Xin – Trademark Portfolio
Entity Type: 01
Ouyang Xin owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as NEROUPE, PACBURY, YINGLOP, and ANDETEPY. Of these, 4 are registered and 1 is pending. The portfolio spans 5 Nice Classification classes, led by Class 28 (Toys & Sporting Goods) and Class 25 (Clothing). Headquartered in Shenzhen.
No.3039, Baoan North Road
Luohu District
Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Ouyang Xin's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Ouyang Xin have?
Ouyang Xin has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 cancelled.
What trademark classes does Ouyang Xin file in?
Ouyang Xin files trademarks across 5 Nice Classification classes. The most active classes are Class 28 (Toys & Sporting Goods), Class 25 (Clothing), Class 3 (Cosmetics & Cleaning), Class 11 (Environmental Control), Class 18 (Leather Goods). Class 28 covers games and playthings; gymnastic and sporting articles; decorations for christmas trees.
What are Ouyang Xin's most well-known trademarks?
Ouyang Xin's registered trademark portfolio includes well-known marks such as NEROUPE, PACBURY, YINGLOP, and ANDETEPY. These are among 4 currently registered trademarks in the portfolio.
What is Ouyang Xin's trademark registration success rate?
Ouyang Xin has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.